LWMI
CLGN icon

Legacy Wealth Management (Idaho)’s CollPlant Biotechnologies CLGN Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.09K Hold
2,318
– – ﹤0.01% 195
2026
Q1 		$12.4K Buy
2,318
+1,971
+568% +$19.9K 0.01% 447
2025
Q4 		$4.86K Buy
+347
New +$7.1K ﹤0.01% 538

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s CLGN Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 2,318 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

Legacy Wealth Management (Idaho) first reported a position in CLGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.4K in Q1 2026. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Legacy Wealth Management (Idaho) held 2,318 shares of CollPlant Biotechnologies worth $8.09K as of Q2 2026.
  • Legacy Wealth Management (Idaho) left its CollPlant Biotechnologies share count unchanged in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q2 2026, its #195 holding.
  • Legacy Wealth Management (Idaho) first reported a position in CollPlant Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • Legacy Wealth Management (Idaho)'s CollPlant Biotechnologies position peaked at $12.4K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.